Kilroy Conor 4
4 · IRONWOOD PHARMACEUTICALS INC · Filed May 13, 2020
Insider Transaction Report
Form 4
Kilroy Conor
SVP, GC & Secretary
Transactions
- Sale
Class A Common Stock
2020-05-11$10.35/sh−158$1,635→ 129,479 total - Sale
Class A Common Stock
2020-05-11$10.35/sh−558$5,775→ 128,921 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on August 1, 2016.
- [F2]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1, 2019.